Nanobac Pharmaceuticals, Incorporated (NNBP)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jul 21, 2026
Nanobac Pharmaceuticals Market Cap
Nanobac Pharmaceuticals has a market cap or net worth of $24.95 thousand as of July 23, 2026. Its market cap has increased by 9,880.40% in one year.
Market Cap
24.95K
Enterprise Value
n/a
Revenue
17.62K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since June 16, 2003, Nanobac Pharmaceuticals's market cap has decreased from 18.83M to 24.95K, a decrease of -99.87%. That is a compound annual growth rate of -24.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 24.95K | 9,880.40% |
| Dec 31, 2025 | 250.00 | - |
| Dec 23, 2024 | 250.00 | - |
| Dec 21, 2023 | 250.00 | - |
| Dec 16, 2022 | 250.00 | -99.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sigyn Therapeutics | 58.49K |
| Regen BioPharma | 56.20K |
| Panbela Therapeutics | 53.89K |
| Itoco | 42.82K |
| Vaxxinity | 25.35K |
| Scopus BioPharma | 21.04K |
| Health Sciences Group | 20.51K |
| Regenicin | 15.35K |